ALINITY C DIRECT LDL
Mexico·Clase I·III. DIAGNOSTIC AGENTS·ABBOTT LABORATORIES DE MEXICO SA DE CV·Registered October 16, 2018ENSAYO PARA LA DETERMINACIÓN DEL COLESTEROL DE LIPOPROTEÍNA DE BAJA DENSIDAD (LDL).
ASSAY FOR THE DETERMINATION OF LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- ENSAYO PARA LA DETERMINACIÓN DEL COLESTEROL DE LIPOPROTEÍNA DE BAJA DENSIDAD (LDL).
- Trade Name (English)
- ASSAY FOR THE DETERMINATION OF LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL.
- Analysis ID
- 2368R2018 SSA
- Registration Date
- October 16, 2018
- Name (Spanish)
- ABBOTT LABORATORIES DE MEXICO SA DE CV
- Name (English)
- ABBOTT LABORATORIES DE MEXICO SA DE CV
Access comprehensive regulatory information for ALINITY C DIRECT LDL (ALINITY C DIRECT LDL) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 2368R2018 SSA and manufactured by ABBOTT LABORATORIES DE MEXICO SA DE CV. The device was registered on October 16, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.